SavedAdd your journal

Journals / Turkish Journal of Urology / 2015 / Cilt: 41 - Sayı: 4

Role of percutaneous posterior tibial nerve stimulation either alone or combined with an anticholinergic agent in treating patients with overactive bladder

Sadık KIZILYEL
AHMET KARAKEÇİ
TUNÇ OZAN
İhsan UNUS
OSMAN BARUT
AHMET RAHMİ ONUR
Pages
208–214
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: PTNS is a safe, simple, and minimally invasive treatment modality in patients with OAB, and it may be suggested either alone or in combination with anticholinergics when conventional treatments fail

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate the efficacy of percutaneous tibial nerve stimulation (PTNS), either alone or combined with an anticholinergic agent, in treating patients with an overactive bladder (OAB) in whom previous conservative treatment failed.Material and methods: In this study, we included a total of 30 female patients with OAB in whom all conventional therapies failed between January 2010 and April 2011.
📊
Key Findings & Data:Patients were randomly divided into three groups: Group 1, PTNS group; Group 2, patients receiving an anticholinergic agent; and Group 3, patients receiving both PTNS and anticholinergic agent.
💡
Conclusion & Impact:Conclusion: PTNS is a safe, simple, and minimally invasive treatment modality in patients with OAB, and it may be suggested either alone or in combination with anticholinergics when conventional treatments fail
🔬Design:Survey & Empirical Study
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: To evaluate the efficacy of percutaneous tibial nerve stimulation (PTNS), either alone or combined with an anticholinergic agent, in treating patients with an overactive bladder (OAB) in whom previous conservative treatment failed.Material and methods: In this study, we included a total of 30 female patients with OAB in whom all conventional therapies failed between January 2010 and April 2011. Patients were randomly divided into three groups: Group 1, PTNS group; Group 2, patients receiving an anticholinergic agent; and Group 3, patients receiving both PTNS and anticholinergic agent. PTNS treatment continued for 12 weeks with each session lasting 30 min. Results: All parameters of the bladder diary significantly improved in all groups (p<0.05). Similarly, all scores measured by questionnaires (UDI-6, IIQ-7, and OABSS) revealed significant improvements in all groups. When the improvements in symptoms were compared among the groups, there was a statistically significantly higher improvement in groups 1 and 3 than in Group 2. Conclusion: PTNS is a safe, simple, and minimally invasive treatment modality in patients with OAB, and it may be suggested either alone or in combination with anticholinergics when conventional treatments fail

🔖

Cite This Article

KIZILYEL, S., KARAKEÇİ, A., OZAN, T., UNUS, İ., BARUT, O., ONUR, A. R. (2015). Role of percutaneous posterior tibial nerve stimulation either alone or combined with an anticholinergic agent in treating patients with overactive bladder. Turkish Journal of Urology, Cilt: 41 - Sayı: 4, 208–214. https://ajindex.com/articles/379759

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-78. [CrossRef] 2. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003;20:327-36. 3. Hashim H, Abrams P. Overactive bladder: an update. Curr Opin Urol 2007;17:231-36. [CrossRef] 4. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study. Eur Urol 2006;50:1306-14. [CrossRef] 5. Ganz ML, Smalarz AM, Krupski TL, Anger JT, Hu JC, Wittrupensen K, Pashos CL. Economic costs of overactive bladder in the United States. Urology 2010;75:526-32. [CrossRef] 6. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance. Br J Obs Gynecol 1997;104:988-93. [CrossRef] 7. Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol 2012;188:2455-63. [CrossRef] 8. Zinkgraf K, Quinn AO, Ketterhagen D, Kreuziger B, Stevenson K. Percutaneous tibial nerve stimulation for treatment of overactive bladder and urinary retention in an elderly population. Urol Nurs 2009;29:30-4. 9. Peters KM, MacDiarmid SA, Wooldridge LS, Leong FC, Shobeiri SA, Rovner ES, et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol 2009;182:1055-61. [CrossRef] 10. Vecchioli-Scaldazza C, Morossetti C, Berouz A, Giannubilio W, Ferrara V. Solifenacin Succinate versus percutaneos tibial nevre stimulation in women with overactive bladder syndrome: Results of a randomized controlled crossover study. Gynecol Obstet Invest 2013;75:230-4. [CrossRef] 11. McGuire EJ, Zhang SC, Horwinski ER, Lytton B. Treatment of motor and sensory detrusor instability by electrical stimulation. J Urol 1983;129:78-9. 12. Stoller ML, Copeland S, Millard RJ. The efficacy of acupuncture in reversing the unstable bladder in pig-tailed monkeys (abstract). J Urol 1987;137:104A. 13.